- Filed
- Nov 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 14, 2025 | 31.35M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 16.55M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 16.43M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 15.08M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 8.35M sh |
| Stock Repurchased | Q3 2025 · Sep 30, 2025 | $44 |
| Stock Repurchased | Q3 2025 · Sep 30, 2024 | $0 |
| Capex | Q3 2025 · Sep 30, 2025 | $22.78K |
| Capex | Q3 2025 · Sep 30, 2024 | $50.51K |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$1.52M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$2.82M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $589.37K |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $593.94K |
| Short Term Debt | Q3 2025 · Sep 30, 2025 | $1.94M |
| Short Term Debt | Q3 2025 · Dec 31, 2024 | $433.98K |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $472.76K |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $326.12K |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | −$5.58M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | −$18.49K |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $23.42M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $19.01M |
| Current Liabilities restated | Q3 2025 · Sep 30, 2024 | $20.23M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $24.28M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $20.01M |
| Total Liabilities restated | Q3 2025 · Sep 30, 2024 | $21.37M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $3.72M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $3.02M |
| Current Assets restated | Q3 2025 · Sep 30, 2024 | $4.38M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $18.71M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $19.99M |
| Total Assets restated | Q3 2025 · Sep 30, 2024 | $22.3M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.02 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.42 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$3.58 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$6.53 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.02 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.42 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$3.58 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$6.53 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $2.92M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $7.12M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $2.22M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $3M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$289.75K |
| Net Income | Q3 2025 · Sep 30, 2025 | −$6.86M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$53.92M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$54.49M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$2.06M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$6.14M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$58.29M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$59.12M |
| Gross Profit | Q3 2025 · Sep 30, 2025 | $2.07M |
| Gross Profit | Q3 2025 · Sep 30, 2025 | $5.52M |
| Gross Profit restated | Q3 2025 · Sep 30, 2024 | $2.78M |
| Gross Profit restated | Q3 2025 · Sep 30, 2024 | $4.8M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $1.91M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $5.17M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $569.73K |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $1.89M |
| Revenue | Q3 2025 · Sep 30, 2025 | $3.98M |
| Revenue | Q3 2025 · Sep 30, 2025 | $10.69M |
| Revenue | Q3 2025 · Sep 30, 2024 | $3.35M |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $6.69M |